The market for Endoscope Reprocessing Device Market is expected to reach XX in 2023.
Endoscope reprocessing involves the cleaning, disinfection, and sterilization of medical instruments and encompasses the steps of cleaning, rinsing, disinfection, secondary rinsing, drying, and storage. It is the fastest-growing segment in the disinfection technologies market due to the rising tide of cleaning standards and mounting pressure for sterilized and disinfected medical devices in hospitals and clinics.
The growing importance of diagnostic and therapeutic endoscopy procedures and the increasing number of minimally invasive surgeries across the globe are some of the key factors contributing to the growth of this market.
With the surge in the use of endoscopes, the risk of infections linked to their reprocessing is also increasing. When endoscopes are used on multiple patients, they become contaminated with microorganisms.
In order to avoid such a risk of infection, endoscopes undergo a detailed and automated multistep process to clean or sterilize them, known as reprocessing. Special care must also be taken while reprocessing endoscopes, as inadequate reprocessing can result in adverse patient outcomes such as tissue irritation from residual reprocessing materials (chemical disinfectants). It is also important that the endoscope be designed in such a way that it can be adequately reprocessed.
The entire endoscopy market is also expected to grow in the coming years, thus propelling the reprocessing and cleaners segment of the market. The infection control market witnessed healthy growth in the last decade owing to the rising aging population and prevalence of chronic diseases, an increase in the number of surgeries performed, and the rising occurrence of hospital-acquired infections. Though stringent regulations and saturation in developed economies will restrict the growth of the market to a certain extent,
North America accounts for the largest share of the infection control market, followed by Europe, while Asia-Pacific is an emerging market. However, Asia is expected to display favorable growth in the coming years, primarily due to a rise in awareness, the growth of an aging population, an increase in the number of surgeries, and growth in per capita income.
Based on product type
Automated endoscope reprocessors (AERs)
Geography
STERIS Plc., Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, Wassenburg Medical B.V., Steelco S.p.A., MEDIVATORS Inc. (Cantel Medical Corp.), Johnson & Johnson, and Minntech Corp.
The market for Endoscope Reprocessing Device Market is expected to reach XX in 2023.
The Endoscope Reprocessing Device Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted to 2016-2023.
The base year of this report is 2015
Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, Wassen burg Medical B.V. are some of the major players in the global market.